rs374902148

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_StrongBP6BP7

The NM_001267550.2(TTN):​c.87111G>A​(p.Glu29037Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000981 in 1,610,788 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000095 ( 0 hom. )

Consequence

TTN
NM_001267550.2 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7

Conservation

PhyloP100: -0.446

Publications

0 publications found
Variant links:
Genes affected
TTN (HGNC:12403): (titin) This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]
TTN-AS1 (HGNC:44124): (TTN antisense RNA 1) This gene encodes a non-coding RNA transcribed from the opposite strand to the titin gene. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 2-178558348-C-T is Benign according to our data. Variant chr2-178558348-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179040. Variant chr2-178558348-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179040. Variant chr2-178558348-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179040. Variant chr2-178558348-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179040. Variant chr2-178558348-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179040. Variant chr2-178558348-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179040. Variant chr2-178558348-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179040. Variant chr2-178558348-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179040. Variant chr2-178558348-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179040. Variant chr2-178558348-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179040. Variant chr2-178558348-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179040. Variant chr2-178558348-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179040. Variant chr2-178558348-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179040. Variant chr2-178558348-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179040. Variant chr2-178558348-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179040. Variant chr2-178558348-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179040. Variant chr2-178558348-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179040. Variant chr2-178558348-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179040. Variant chr2-178558348-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179040. Variant chr2-178558348-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179040.
BP7
Synonymous conserved (PhyloP=-0.446 with no splicing effect.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTNNM_001267550.2 linkc.87111G>A p.Glu29037Glu synonymous_variant Exon 327 of 363 ENST00000589042.5 NP_001254479.2 A0A0A0MTS7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTNENST00000589042.5 linkc.87111G>A p.Glu29037Glu synonymous_variant Exon 327 of 363 5 NM_001267550.2 ENSP00000467141.1 A0A0A0MTS7

Frequencies

GnomAD3 genomes
AF:
0.000125
AC:
19
AN:
152208
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00461
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000216
AC:
53
AN:
245114
AF XY:
0.000233
show subpopulations
Gnomad AFR exome
AF:
0.0000651
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00431
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000628
Gnomad OTH exome
AF:
0.000336
GnomAD4 exome
AF:
0.0000953
AC:
139
AN:
1458580
Hom.:
0
Cov.:
32
AF XY:
0.000102
AC XY:
74
AN XY:
725292
show subpopulations
African (AFR)
AF:
0.0000301
AC:
1
AN:
33250
American (AMR)
AF:
0.00
AC:
0
AN:
43990
Ashkenazi Jewish (ASJ)
AF:
0.00406
AC:
106
AN:
26078
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39526
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85300
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53344
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5756
European-Non Finnish (NFE)
AF:
0.0000135
AC:
15
AN:
1111094
Other (OTH)
AF:
0.000282
AC:
17
AN:
60242
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
9
18
26
35
44
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000125
AC:
19
AN:
152208
Hom.:
0
Cov.:
33
AF XY:
0.000121
AC XY:
9
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41450
American (AMR)
AF:
0.00
AC:
0
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00461
AC:
16
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5198
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68036
Other (OTH)
AF:
0.000478
AC:
1
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000510
Hom.:
0
Bravo
AF:
0.000125

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:4
Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BP1;BP6 -

Dec 17, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Glu26469Glu in exon 276 of TTN: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 1/8188 European Am erican chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs374902148). Glu26469Glu in exon 276 of TTN (rs374902148; allele frequency = 1/8188) ** -

Dec 02, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

May 02, 2018
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiomyopathy Uncertain:1
Jun 16, 2016
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TTN: BP4, BP7 -

Cardiovascular phenotype Benign:1
Mar 20, 2020
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
6.4
DANN
Benign
0.76
PhyloP100
-0.45
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs374902148; hg19: chr2-179423075; COSMIC: COSV60066205; API